Navigation Links
Immtech Reports Fiscal Second Quarter 2008 Results
Date:11/8/2007

NEW YORK, Nov. 8 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (Amex: IMM) today announced results for its fiscal second quarter ended September 30, 2007.

For the three months ended September 30, 2007, revenues were $1,030,000, as compared to $491,000 for the three months ended September 30, 2006. The increase was primarily attributable to revenues relating to a licensing agreement and research agreement. Loss from operations for the three months ended September 30, 2007 was $3,466,000, as compared to a loss from operations of $1,753,000 for the three months ended June 30, 2006. The three month period ended September 30, 2006 included a receivable of $1,874,000 relating to the Neurochem litigation award. Net loss attributable to common stockholders for the three months ended September 30, 2007 was $3,469,000, or $0.23 per share, compared to a loss of $1,758,000, or $0.13 per share, in the previous year.

At September 30, 2007, unrestricted cash and cash equivalents were $9,840,000 as compared to $12,462,000 at March 31, 2007. For the same periods, restricted funds on deposit were $694,000 and $3,119,000, respectively. Subsequent to September 30, 2007, a payment of $5,123,000 was received to further the development of pafuramidine, the Company's oral drug candidate, in the Phase III African sleeping sickness trial.

During the three-month period ended September 30, 2007, several significant milestones were achieved. In addition to the Par Pharmaceutical agreement, Immtech received orphan drug status from the USFDA for pafuramidine to treat malaria and African sleeping sickness, added a new board member and a strategic advisor to the team, and received from China's State Food and Drug Administra
'/>"/>

SOURCE Immtech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
2. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
3. Chinese SFDA Grants Immtech Fast Track Status
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
6. Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. Spherix Reports Second Quarter Earnings
9. Tapestry Reports Second Quarter 2007 Results
10. Callisto Reports on Second-Quarter 2007 Milestones
11. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... MAHWAH, N.J. , July 30, 2014 Stryker brand ... playing this week at the 3M Championship Champions Tour event near ... Twin Cities, in Blaine . Stryker is the ... Tour. Starting Friday, August 1 st through ... the Stryker Mobility Zone; an on-site joint health destination located in ...
(Date:7/30/2014)... 30, 2014 Cynosure, Inc. (NASDAQ: ... treatments for non-invasive and minimally invasive applications, today announced that ... Operating Officer and Chief Financial Officer Timothy W. Baker ... Baker, 53, will continue to serve as CFO and will ... who remains Chairman and Chief Executive Officer. ...
(Date:7/30/2014)... SANTA CLARA, Calif. , July 30, 2014 /PRNewswire/ ... innovation economy, released a study today that ... venture-backed biopharma and medical device companies.  According to the ... healthcare saw the biggest potential returns since SVB started ... the year of the IPO.  Built on solid healthcare ...
Breaking Medicine Technology:Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3
... 2011 Hypoxic (oxygen-deprived) tumor cells usually resist radiation ... cancer. Researcher Xin Chen, Ph.D. believes that ... with malignant solid tumors in areas such as the ... an assistant professor in the Department Radiation Oncology at ...
... July 26, 2011 SCOLR Pharma, Inc. (OTC: SCLR) today ... ended June 30, 2011 and also provided updates on a ... the Company issued an aggregate of $1.2 million principal amount ... "Debentures") in a private offering of Debentures. The Company intends ...
Cached Medicine Technology:Arkansas Researcher is Exploring MR-Guided Focused Ultrasound as an Adjuvant Therapy to Radiation 2Arkansas Researcher is Exploring MR-Guided Focused Ultrasound as an Adjuvant Therapy to Radiation 3SCOLR Pharma, Inc. Announces Second Quarter 2011 Financial Results 2SCOLR Pharma, Inc. Announces Second Quarter 2011 Financial Results 3SCOLR Pharma, Inc. Announces Second Quarter 2011 Financial Results 4SCOLR Pharma, Inc. Announces Second Quarter 2011 Financial Results 5SCOLR Pharma, Inc. Announces Second Quarter 2011 Financial Results 6
(Date:7/30/2014)... York (PRWEB) July 30, 2014 The ... brain bleeding has filed a Xarelto lawsuit ( http://www.xareltolawsuitcenter.com/ ... blood thinner, Bernstein Liebhard LLP reports. According to the ... the District of Vermont on July 25th, the decedent ... he suffered an irreversible brain bleed that ultimately led ...
(Date:7/30/2014)... The phrase "we caught it early" is possibly the ... of a cancer diagnosis. Combating cancer in its earliest ... part of the body, gives patients the best chances ... prostate and other forms of cancer are touted for ... recommend cancer screenings as a precautionary measure, especially for ...
(Date:7/30/2014)... VA (PRWEB) July 30, 2014 The ... 2014-2015 Board of Directors. Sandra Aiken Chack will serve ... month at the EDNF 2014 Annual Learning Conference in ... Foundation has an ambitious agenda ahead of us. From ... Care & Research at the Greater Baltimore Medical Center ...
(Date:7/30/2014)... Children’s Hospital of Michigan Foundation and Kohl’s ... p.m. to 7 p.m. Wednesday, August 6 at the ... MI 48152). The event will feature Detroit Red Wings ... snacks and local public safety officials. Kohl’s will present ... Michigan Foundation. , The gift supports Kohl’s Injury ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Frozen shoulder (Adhesive ... more likely to develop this nasty condition which occurs most ... and can last up to two and half years if ... frozen shoulder, and with good reason: it can render your ... — that is, if you aren't in too much pain ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 3Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 3Health News:Ehlers-Danlos National Foundation Announces New Leadership 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 3Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 4Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4
... accidents were the biggest killers. Now it appears that the ... to the fatalities caused by road accidents. , ... University of Edinburgh, has provided statistics which demonstrates the increase ... annually; in contrast, MRSA cases had dropped by 4.3 per ...
... International Myeloma Foundation (IMF) - supporting research and ... families, researchers and physicians// - today said physicians ... dexamethasone when treating patients with multiple myeloma. ... standard therapy for the treatment of myeloma alone ...
... of lung cancer among people with chronic obstructive pulmonary ... corticosteroids are medications that are approved for use in ... ,How inhaled corticosteroids work in asthma is still ... reduce inflammation in the airways thereby improving symptoms associated ...
... in developing nations is undermining essential health services, including ... Organization Director-General Margaret Chan said on Tuesday in Singapore ... ,Thousands of health care professionals have left their ... jobs in wealthier countries, Reuters reports. ,According ...
... clinical disease progression and death in HIV-1-infected women ... in the Journal of Acquired Immune Deficiency Syndromes. ... HIV-infected Tanzanian women and recommends screening for depression ... comprehensive HIV care. ,There is increasing ...
... has signed an exclusive worldwide Collaborative Research and ... delivery technologies, including the Medidur technology in ophthalmic ... agreement, pSivida will receive up to $155 million ... ,Pfizer will have an exclusive license to ...
Cached Medicine News:Health News:New Clinical Trial Results Could Improve Survival for Myeloma Patients 2Health News:New Clinical Trial Results Could Improve Survival for Myeloma Patients 3Health News:Inhaled Corticosteroids may Reduce Lung Cancer Risk 2Health News:Depression Increases the Risk of Disease Progression and Death in HIV-positive Women 2
Cross action, round handle, maximum opening 2.8 mm....
Irrigating nucleus chopper, tip angled 30 to side wedge shaped inferior edge with blunt tip and front notch for engaging iris end opening, 19 gauge. For use in the right hand....
Small pupil irrigating nucleus chopper, wedge-shaped inferior edge with, blunt tip and front notch, for engaging the iris, 0.6 mm dual sideports, 20 gauge....
Irrigating nucleus chopper, 1.5 mm long wedge-shaped, inferior edge with round end, 0.6 mm dual sideports 20 gauge....
Medicine Products: